Delivery Order SPE2DX22D0090-SPE2D826FAE9D
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,257.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, with completion expected by October 21, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order is to be performed at AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $1,746.48 delivery order to AmerisourceBergen Drug Corp on April 29, 2025, with completion targeted for April 30, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The contract supports federal pharmaceutical and medical supply...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $11,439.51 to AmerisourceBergen Drug Corp on August 26, 2025, with completion scheduled for August 27, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract covers pharmaceutical and medical supply...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $228,023.12 to AmerisourceBergen Drug Corp on August 13, 2025, for pharmaceutical and medical supply delivery. This firm fixed-price, non-competitive delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The work will be performed at the company's Corporate...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $289,020.28 to AmerisourceBergen Drug Corp on January 2, 2026, with an ultimate completion date of January 5, 2026. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order for pharmaceutical products and medical supplies to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on November 10, 2025. The contract is a firm fixed-price delivery order with a ceiling value of $1,363.11 and an ultimate completion date of November 12, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,117.55 to AmerisourceBergen Drug Corp on December 15, 2025, with an ultimate completion date of December 16, 2025. This is a firm fixed price delivery order issued under a larger contract vehicle and represents a non-competitive award to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, valued at $5,494.85 with a completion date of December 3, 2025. This competitive award, with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 through December 2026. The delivery order carries firm fixed pricing...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order, valued at $10,756.02, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999 through December 2026. The award was made through competitive...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $16,602.00 to AmerisourceBergen Drug Corp on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order was issued...
- SPE2DX22D0090Indefinite Delivery Contract
- SPE2DX22D0090-SPE2D826FAE9DDelivery Order
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for pharmaceutical and medical supplies with a ceiling value of $5,936.04 and an ultimate completion date of January 5, 2026. This competitive award carries firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order requires performance at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical federal medical procurement needs through its extensive portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's DLA IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of medical products to support military healthcare programs worldwide, including customers such as the Defense Health Agency and the U.S. Coast Guard. This delivery order exemplifies the company's ongoing role as a key vendor for federal medical supply acquisition across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 1/1/26 |